SAGE remember when you thought you were going to BIG

Discussion in 'Sage Therapeutics' started by anonymous, Feb 5, 2020 at 11:34 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Please all of you snowflakes leave our company! Please! Please!! The strong only thrive when challenged! The weak post fake news on cafepharma.
     

  2. anonymous

    anonymous Guest

    Hey turn off your Fox News channel for a minute and realize that once you lose your sales force, you’ve lost any chance at righting this ship. I agree with the original poster!!!
     
  3. anonymous

    anonymous Guest

    ding ding ding! Correct. No site, no patients, no need for TBS and KAM
     
  4. anonymous

    anonymous Guest

    This is all very sad. A desperation focus strategy announced at the end of January...Town Hall day before supposed payouts (which are shrouded in mystery).

    Merit increases...maybe sometime. Earnings call late February, so the town hall won’t offer much clarity....

    Skills building to keep training busy...maybe it’ll help resumes...

    An absolute mess...a sad sloppy mess.
     
  5. anonymous

    anonymous Guest


    Fake news? It has ALL COME TRUE. Go Away idiot! This is the only forum where valuable information is shared. If you aren't near the "Targeted Sites," best to have a game plan. THEY WILL NOT BE KIND HERE. WHEN THEY LET YOU GO, THERE WILL BE NO SEVERANCE. Cover your ass and do what you need to do!
     
  6. anonymous

    anonymous Guest

    The same person keeps posting “fake news” everywhere but all of the criticism has come true if you read back through the post history. Zulresso was doomed to fail ever since it was originally developed for comatose patients where sedation wasn’t an issue and it was designed to be administered over multiple days. It was never meant to be developed for PPD. Unfortunately this company built a house of cards on top of it.
     
  7. anonymous

    anonymous Guest



    it’s like a Hollywood set. Looks like areal house from the outside but it’s really a fake front held up by 2 x 4s
     
  8. anonymous

    anonymous Guest

    They can fix it if they make major cuts. They hired way too many people throughout the whole company anyway, most likely due to arrogance and micromanagement mentalities.
     
  9. anonymous

    anonymous Guest

    Yea Sage Therapeutics = BUST
     
  10. anonymous

    anonymous Guest

    Message to sales reps: Are you boring? In Sales, you cannot afford to be seen as boring. Make sure after your greeting that your first business words really capture the attention of who you are talking with. To do that your first words likely need to create curiosity about what you ultimately want to discuss. Far too many sales people don’t take the time to plan to be interesting and relevant in advance. If you are better at selling, you will make your bonus $s and won't have to whine on CP!
     
  11. anonymous

    anonymous Guest

    F U

    you sold the field of shiit goods. This place is crap. We left good jobs to come to your super hero crap hole
     
  12. anonymous

    anonymous Guest

    Hahahahaha

    you sold a bill of goods that turned out to be garbage. So we will sit and get paid until we find a better opportunity
     
  13. anonymous

    anonymous Guest

     
  14. anonymous

    anonymous Guest

    Control Emotions drives Confidence resulting in Behavior needed to excel and achieve goals! #sageisforpatients
     
  15. anonymous

    anonymous Guest

     
  16. anonymous

    anonymous Guest

    hahahaha - I love your sarcasm!
     
  17. anonymous

    anonymous Guest

    Earnings will probably be relatively stagnant for Q4 19.

    Q3 19 was $1.5M in Zulresso and $2.1M collaboration.

    Hopefully will be at least the same, if not slightly better. Either way, the market won’t love it, especially with all the other outside forces weighing in.
     
  18. anonymous

    anonymous Guest

    Those aren't earnings, that's top-line revenue. The company has no earnings and will report a very high loss tomorrow. Likely $4-5M for Zulresso. Sage isn't valued for Zulresso though, so they will be more focused on 217 clarity.
     
  19. anonymous

    anonymous Guest

    Playing the devil’s advocate, but maybe Sage will somehow pull through.
     
  20. anonymous

    anonymous Guest

    Hey Jerry here's my first business words: eat shit!